RxDoctor Payments Data

Martin Gelbard

Urology · Santa Monica, CANPI 1912996851

Payments from drug & device makers

$142,287in general payments, 2019–2025

Across 196 payments — averaging $725.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endo Pharmaceuticals Inc.$125K
  • Endo USA, Inc.$15K
  • Metuchen Pharmaceuticals$2K
  • Rochester Medical Corporation$282
  • C. R. Bard, Inc. & Subsidiaries$171
  • Progenics Pharmaceuticals, Inc.$13
  • plus $34 from 3 others

What the payments were for

  • Consulting fees$50,84836%
  • Speaking & faculty fees$70,98550%
  • Travel & lodging$15,30511%
  • Food & beverage$5,1494%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Endo Pharmaceuticals Inc.128$125,263
Endo USA, Inc.28$14,966
Metuchen Pharmaceuticals2$1,557
Rochester Medical Corporation23$282
C. R. Bard, Inc. & Subsidiaries11$171
Progenics Pharmaceuticals, Inc.1$13
Medtronic1$12
Astellas Pharma US Inc1$11
Clarus Therapeutics Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$142,287 in reported general payments places this provider in the 90th percentile of 1,324 urology providers in California.

See all urology providers in California

Other urology in Santa Monica

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →